Old Web
English
Sign In
Acemap
>
authorDetail
>
Miguel Angel Abellanas
Miguel Angel Abellanas
University of Navarra
Neuroinflammation
Immunology
Parkinson's disease
Biology
Microglia
4
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition.
2020
Estefanía Rojo-Bustamante
Ignacio Íñigo-Marco
Miguel Angel Abellanas
Rodrigo Vinueza-Gavilanes
Ana Baltanás
Esther Luquin
Montserrat Arrasate
María S. Aymerich
Show All
Source
Cite
Save
Citations (2)
Cannabinoid receptor type 2 as a therapeutic target for Parkinson's disease
2020
Miguel Angel Abellanas
María S. Aymerich
Show All
Source
Cite
Save
Citations (0)
Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model
2019
Frontiers in Immunology
Daniela Elgueta
Francisco Contreras
Carolina Prado
Andro Montoya
Valentina Ugalde
Ornella Chovar
Roque Villagra
Claudio Henríquez
Miguel Angel Abellanas
María S. Aymerich
Rarael Franco
Rodrigo Pacheco
Show All
Source
Cite
Save
Citations (17)
Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions
2019
Journal of Neuroinflammation
Miguel Angel Abellanas
Marta Zamarbide
Leyre Basurco
Esther Luquin
Marta García-Granero
Pedro Clavero
Patxi San Martin-Uriz
Amaia Vilas
Elisa Mengual
Sandra Hervas-Stubbs
María S. Aymerich
Show All
Source
Cite
Save
Citations (11)
1